Donate to Illuminate Contact TSF
Facebook Logo Twitter Logo Youtube Logo Instagram Logo LinkedIn Logo TikTok Logo Blue Sky Logo

Archives: Research Summaries

The real-world applicability of the 2023 international myelin oligodendrocyte glycoprotein antibody-associated disease criteria in a Latin American cohort

The real-world applicability of the 2023 international myelin oligodendrocyte glycoprotein antibody-associated disease criteria in a Latin American cohort

Journal: European Journal of Neurology; September 17, 2024

Author(s): Edgar Carnero Contentti, Claudia Pestchanker, Ethel Ciampi, Sheila Castro Suarez, Cesar Caparo Zamalloa, Vanesa Daccach Marques, Katharina Messias, José Ignacio Gortari, Verónica Tkachuk, Berenice Silva, Carolina Mainella, Saúl Reyes, Jaime Toro, Juan Rodriguez, Edgar Correa-Diaz, Juan I. Rojas, Friedemann Paul

Evaluating the 2023 diagnostic criteria for MOGAD in real-world settings in Latin America


Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

Journal: JAMA Neurology; September 3, 2024

Author(s): Young Nam Kwon, Boram Kim, Jun-Soon Kim, Kyung Seok Park, Da-Young Seo, Hyunjin Kim, Eun-Jae Lee, Young-Min Lim, Hyunjin Ju, Yeon Hak Chung, Ju-Hong Min, Tai-Seung Nam, Sooyoung Kim, Eunhee Sohn, Kyong Jin Shin, Jin Myoung Seok, Sunyoung Kim, Jong Seok Bae, Sukyoon Lee, Seong-il Oh, Yu Jin Jung, Jinseok Park, Seung Hyun Kim, Ki Hoon Kim, Ho Jin Kim, Jae Ho Jung, Seong-Joon Kim, Seung Woo Kim, Myoung-jin Jang, Jung-Joon Sung, Patrick Waters, Ha Young Shin, Sung-Min Kim

Does time taken to treat the first MOGAD attack affect the disease course? A study from South Korea


Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD

Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD

Journal: Journal of Neurology, Neurosurgery, & Psychiatry; December 1, 2024

Author(s): Vivien Häußler, Corinna Trebst, Daniel Engels, Hanna Pellkofer, Joachim Havla, Ankelien Duchow, Patrick Schindler, Carolin Schwake, Thivya Pakeerathan, Katinka Fischer, Marius Ringelstein, Gero Lindenblatt, Martin W Hümmert, Daria Tkachenko, Franziska Bütow, Katrin Giglhuber, Martina Flaskamp, Insa Schiffmann, Mirjam Korporal-Kuhnke, Sven Jarius, Eva Dawin, Lisa Revie, Makbule Senel, Mariella Herfurth, Annette Walter, Mosche Pompsch, Ingo Kleiter, Klemens Angstwurm, Matthias Kaste, Matthias Grothe, Jonathan Wickel, Paulus Stefan Rommer, Jörn Peter Sieb, Markus Krämer, Florian Then Bergh, Hayrettin Tumani, Luisa Klotz, Brigitte Wildemann, Orhan Aktas, Ilya Ayzenberg, Judith Bellmann-Strobl, Friedemann Paul, Tania Kümpfel, Tim Friede, Achim Berthele, Jan-Patrick Stellmann on behalf of the Neuromyelitis optica study group (NEMOS)

How are immunosuppressive treatments chosen and how effective are they in normal care?


Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision

Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision

Journal: Journal of Neurology; December 1, 2024

Author(s): Mihaela Nicolescu, Vivien Häußler, Friedemann Paul, Frederike Cosima Oertel, Patrick Schindler, Judith Bellmann Strobl, Markus Krumbholz, Martin W. Hümmert, Franziska Bütow, Daria Tkachenko, Corinna Trebst, Charlotte Schubert, Ilya Ayzenberg, Carolin Schwake, Thivya Pakeerathan, Katinka Fischer, Orhan Aktas, Marius Ringelstein, Markus Kraemer, Clemens Warnke, Matthias Grothe, Matthias Kaste, Klemens Angstwurm, Peter Kern, on behalf of the Neuromyelitis Optica Study Group (NEMOS)

How is vision and vision-related quality of life affected in NMOSD, MOGAD, and MS patients?


Quality of life in patients with myelin oligodendrocyte glycoprotein antibody associated disease compared to patients with AQP4-IgG positive neuromyelitis optica spectrum disorders: A Korean multicenter study

Quality of life in patients with myelin oligodendrocyte glycoprotein antibody associated disease compared to patients with AQP4-IgG positive neuromyelitis optica spectrum disorders: A Korean multicenter study

Journal: Multiple Sclerosis and Related Disorders; November 1, 2024

Author(s): Hyun Ji Lyou, Ha Young Shin, Hye Lim Lee, Young Nam Kwon, Seong-il Oh, Jeeyoung Oh, Eun Bin Cho, Sunyoung Kim, Seol-Hee Baek, Byung-Jo Kim, Eunhee Sohn, Jin Myoung Seok, Ju-Hong Min, Seung Woo Kim, Byoung Joon Kim

Comparing quality of life in NMOSD and MOGAD patients in South Korea


Industry Partners

Community Partners